Who We Are

The New Jersey Life Sciences Vendors Alliance (NJLSVA) is a coalition of businesses, individuals and academia who provide goods and services to New Jersey’s life sciences companies.

The NJLSVA was founded to educate suppliers on trends in industry procurement and public policy that affects the life sciences industry.

Choose NJ’s RFP Watch

Choose New Jersey’s RFP Watch provides up-to-date information on business opportunities throughout the Garden State at a cost that is affordable for all companies – with a place of business in New Jersey – large and small.

To learn more click here

Former NIH Director: Sequester Will Be ‘Disaster for Research’

Washington, DC, February 22, 2013 — In a Washington Post interview conducted by Dylan Matthews, Dr. Elias Zerhouni sounded the alarm regarding the potential damaging impact that a federal budget sequestration could have on innovation and research in the United States.

Dr. Zerhouni led the National Institutes of Health (NIH) from 2002 to 2008 and currently is director of research and development at Sanofi, a French pharmaceutical firm.  

Asked what impact an 8.2 percent across-the-board cut would have on the NIH, Dr. Zerhouni, said, “I think the suddenness of it and the depth of it would be a disaster for research, which is not an activity that you can turn on and off from year to year.  It’s an activity that takes time.”

The most impacted, Dr. Zerhouni added “are the young, new investigator scientists, who are coming into science, and will now abandon the field of science.  There will be a generational gap created.”

Dr. Zerhouni told the Post’s Matthews, “People have crocodile tears for all the various types of cuts, but this kind of cut is damaging.  It’s not something that you can manage year to year.  It’s an investment.  They cannot go up and down with the political winds.”

To read Mr. Matthews’ full interview with Dr. Zerhouni in The Washington Post, click here.